Alaunos Therapeutics Inc (STU:WEK)
€ 1.66 0 (-4.82%) Market Cap: 338.23 Mil Enterprise Value: 276.94 Mil PE Ratio: 0 PB Ratio: 0.84 GF Score: 55/100

Q3 2020 ZIOPHARM Oncology Inc Earnings Call Transcript

Nov 05, 2020 / 09:30PM GMT
Release Date Price: €2.06
Operator

Thank you for standing by. This is the conference operator. Welcome to Ziopharm Oncology Third Quarter 2020 Earnings Conference Call.

(Operator Instructions) And the conference is being recorded. (Operator Instructions)

I would now like to turn the conference over to Chris Taylor, Vice President of Investor Relations and Corporate Communications. Please go ahead.

Christopher Taylor
ZIOPHARM Oncology, Inc. - VP of IR & Corporate Communications

Thank you, operator. Good afternoon, and welcome to the Ziopharm Oncology conference call and webcast to review results for the third quarter ended September 30, 2020. This afternoon, we filed our 10-Q and issued our third quarter financial results release, both of which are available in the Investors section of our website, ziopharm.com.

For informational purposes, we have included in our webcast a set of PowerPoint slides to accompany today's commentary. These slides can also be found in the Investors section of our website.

During this call, the company will make several

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot